secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001100682-24-000025
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Q2 revenue falls 3.2% to $1.03B; slashes FY24 guidance on weak demand
--------------------------------------------------------------------------------

- GAAP EPS $1.74 (-7.9% YoY); Non-GAAP EPS $2.80 (+4.1%), Non-GAAP net income $144.9M (+4.8%).
- DSA organic revenue -5.0%, RMS organic -3.9%; Manufacturing organic +3.7%.
- Board authorized new $1.0B share repurchase plan, replacing prior $1.3B authorization.
- FY24 guided GAAP EPS $5.65-$5.95 (prior $7.60-$8.10); Non-GAAP EPS $9.90-$10.20 (prior $10.90-$11.40).
- Restructuring expected to yield >$150M annual savings; ~$100M realized in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000110068224000025/0001100682-24-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000110068224000025/crl-20240807.htm
  HTML page:      https://secwatch.observer/filing/0001100682-24-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer